Revenue and Growth - Revenue for the three months ended June 30, 2025, was $8,054,000, a significant increase from $967,000 in the same period of 2024, representing a growth of 731%[122] - Gross margin for the six months ended June 30, 2025, was $8,783,000, compared to $761,000 for the same period in 2024, indicating a substantial improvement[122] Expenses - Research and development expenses decreased to $20,933,000 for the six months ended June 30, 2025, down from $25,287,000 in 2024, reflecting cost optimization measures[130] - General and administrative expenses increased to $45,787,000 for the six months ended June 30, 2025, compared to $36,186,000 in 2024, driven by higher strategic business development costs[131] Net Loss and Financial Position - The net loss for the six months ended June 30, 2025, was $68,004,000, a decrease from $122,518,000 in the same period of 2024, showing a reduction in losses[122] - Cash and cash equivalents as of June 30, 2025, were $297.7 million, with short-term investments of $123.1 million and no debt[137] - The company has an accumulated deficit of $408.7 million as of June 30, 2025, indicating ongoing financial challenges[137] Funding and Commitments - The company issued and sold 4,548,127 shares of Class A common stock for gross proceeds of $102.4 million during the six months ended June 30, 2025[136] - The company entered into a purchase commitment for additional long-term commitments totaling $34.8 million to support the development of future NuScale Power Modules[146] - The company expects to have sufficient funds to cover R&D activities and operating cash needs for the next twelve months, but may require additional funds as it transitions to commercialization[139] Future Payments and Commitments - Total payments due by year amount to $194,479,000, with $86,065,000 due in 2026 and $85,928,000 in 2027[148] - Materials purchase commitments for LLM total $99,514,000, with $54,476,000 due in 2025[148] - Services commitments total $25,833,000, with $10,729,000 due in 2026[148] - Sales and marketing agreements total $52,200,000, with $34,800,000 due in 2027[148] - NuScale may owe up to $7.7 million to the USTDA based on revenue earned under technical assistance grant programs[149] Market Risk - There have been no material changes in the company's market risk disclosures from the previous annual report[150]

Company Overview and Strategy - NuScale is positioned as a global leader in Small Modular Reactor (SMR) technology, founded in 2007 and years ahead of the competition[8, 9] - The company's SMR technology is the only one approved by the U S Nuclear Regulatory Commission (NRC)[11, 12, 13] - NuScale's strategic partner, ENTRA1, commercializes SMR technology by developing, financing, and operating energy production plants[16, 18, 20] - NuScale remains optimistic about securing a firm order by the end of 2025[23] Regulatory and Project Updates - NuScale is expected to benefit from regulatory tailwinds, including the Inflation Reduction Act and the ADVANCE Act, with multi-billion dollar federal support[24] - The RoPower project in Romania is progressing, with an IAEA SEED advisory mission visiting the site in June 2025[25, 27] - NuScale continues to advance its work to provide six NuScale Power Modules™ to RoPower to support their project at a decommissioned coal plant site in Doicești, Romania[27] Financial Performance - NuScale's Q2 2025 revenue was $8.1 million[31] - Operating expenses for Q2 2025 were $44.9 million, remaining well below the $69.9 million per quarter average in 2023[31, 32] - As of June 30, 2025, the company's liquidity and capital resources totaled $489.9 million[31]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________ FORM 8-K __________________________________ CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 7, 2025 NuScale Power Corporation (Exact name of registrant as specified in its charter) (State or other jurisdiction Delaware 001-39736 98-1588588 (Commission File Number) (I.R.S. Employer Identification No.) 1100 NE ...

Core Viewpoint - NuScale Power is set to report its second-quarter 2025 results, with expectations of significant revenue growth and a widening loss per share compared to the previous year [1][3]. Financial Performance - The Zacks Consensus Estimate for second-quarter revenues is $9.07 million, reflecting an 834.54% increase from the same quarter last year [1]. - The estimated loss for the second quarter is 12 cents per share, which has widened by a penny over the past month, indicating a year-over-year increase of 61.29% [1]. Market Position and Demand - NuScale Power's performance is likely to benefit from strong electricity demand driven by AI-powered data centers and the global shift towards clean energy solutions [3]. - The company is focusing on strategic initiatives to align resources for commercialization and securing revenue-generating contracts [3]. Technological Advancements - Significant progress has been made in the manufacturing and commercialization of Small Modular Reactor (SMR) technology, with key partnerships established with Doosan Interability and ENTRA1 Energy [4]. - The collaboration with ENTRA1 Energy is designed to mitigate risks and align with customer requirements, which are crucial for the success of SMR deployment [5]. Stock Performance - NuScale Power shares have increased by 142% year-to-date, outperforming the Zacks Computer & Technology sector's return of 9.2% and the Zacks Electronics-Power Generation industry's rise of 140.1% [6]. - The company's shares have also outperformed its closest peer, BWX Technologies, which has returned 28.8% in the same period [6]. Industry Trends - The demand for energy is expected to rise significantly, particularly from data centers, which are projected to triple their energy use over the next three years, accounting for 12% of U.S. electricity consumption by 2028 [15]. - Major technology companies like Meta Platforms, Microsoft, Alphabet, and Oracle are increasingly committing to nuclear energy, including SMR technology, to meet sustainability goals [16][17]. Competitive Landscape - Despite advancements, NuScale Power faces stiff competition from companies like Oklo and BWX Technologies in the SMR sector [18]. - Oklo has recently signed a memorandum of understanding with Korea Hydro & Nuclear Power to advance its nuclear technology, with its shares surging 260% year-to-date [19]. Conclusion - NuScale Power's advancements in SMR technology and partnerships position it as a key player in sustainable energy, but challenges remain in a competitive market and concerns over valuation persist [20][21].

Core Viewpoint - The nuclear power sector experienced a significant increase in stock prices, driven by positive earnings guidance from BWX Technologies for the fiscal year 2025 [1] Company Summaries - BWX Technologies (BWXT.US) saw its stock rise over 16% after raising its earnings guidance for the fiscal year 2025 [1] - Oklo Inc (OKLO.US) experienced a stock increase of over 8.5% [1] - NuScale Power (SMR.US) had a stock price increase of over 3.6% [1] - Duke Energy (DUK.US) saw its stock rise by over 2% [1]

Core Viewpoint - Fluor's decision to sell a significant portion of its NuScale shares has led to a decline in NuScale's stock price, despite the company's strong performance [1][5]. Group 1: Fluor's Financial Performance - Fluor reported a 6% year-over-year decline in sales and nearly a 50% cut in adjusted profit [3]. - The gains from NuScale shares contributed $3.2 billion in pre-tax mark-to-market gains for Fluor in Q2, but also introduced volatility in Fluor's financial results [3][4]. Group 2: Share Conversion and Market Impact - Fluor plans to convert 15 million Class B NuScale shares into Class A shares, which may be sold for cash [4]. - This conversion aims to simplify accounting and return value to shareholders, but it raises concerns about flooding the market with additional shares, potentially depressing NuScale's stock price [5][6]. Group 3: Stock Performance and Investor Sentiment - NuScale's stock has increased fivefold over the past year, but the new risks associated with Fluor's share sale have prompted investors to consider selling [6].

Group 1 - China Biopharmaceutical (1177.HK) saw a rise of over 3% after announcing a successful licensing agreement with Merck for its PD-1/VEGF dual antibody, expecting a $300 million milestone payment soon [1] - CSPC Pharmaceutical Group (1093.HK) increased by over 5% following the announcement of an exclusive licensing agreement with Madrigal Pharmaceuticals for the global development of its GLP-1 receptor agonist SYH2086 [1] - Youzan (8083.HK) surged over 7% as it projected a revenue of approximately 709 to 719 million RMB for the first half of the year, a year-on-year increase of about 3.3% to 4.8%, and a net profit of 68 to 74 million RMB, marking a turnaround from a loss last year [1] Group 2 - Xingsheng International (6058.HK) rose nearly 18% after the bank announced its commitment to embrace technological transformation and explore stablecoins and AI initiatives [2] - New Oriental Education (9901.HK) fell nearly 4% after reporting a 9.4% year-on-year increase in net revenue to $1.243 billion for the fourth quarter of fiscal year 2025, but a 73.7% drop in net profit [2] - Kingdee International (0268.HK) saw a rise of over 7% as it announced a board meeting to review its interim results and potential dividend distribution [2] Group 3 - Macau gaming stocks rose, with MGM China (2282.HK) up over 4% after Macquarie raised its forecast for Macau's total gaming revenue for 2025 by 5% to 235.7 billion RMB, indicating a year-on-year growth of 4% [3] - Gold stocks in Hong Kong continued to decline, with Tongguan Gold (0340.HK) dropping over 9% for six consecutive days, as spot gold prices fell below $3,270 per ounce [4] - Kangfang Biopharma (9926.HK) rose nearly 5% after announcing the completion of the first patient dosing in a pivotal clinical trial for its PD-1/VEGF dual-specific antibody [4] Group 4 - Weishi Jiajie (0856.HK) increased by over 3% as a report indicated that its Southeast Asia business is expected to see a significant revenue increase of 74% in 2024, with net profit contributing about 51% [5] Group 5 - Meta (META.US) exceeded revenue expectations and provided strong guidance for the current quarter, leading to an after-hours increase of over 11% [6] - Microsoft (MSFT.US) reported an 18% year-on-year growth in revenue, driven by its cloud business, with Azure revenue up 34% for the full year, resulting in an after-hours increase of over 8% [6] - Wingstop (WING.US) surged by 26.85% after reporting adjusted earnings per share of $1.00 for the second quarter, exceeding analyst expectations [6] Group 6 - Several biopharmaceutical stocks surged, with Replimune (REPL.US) up 101.33% following news of regulatory changes at the FDA that may ease pressure on gene therapy and vaccine companies [7] - Marvell Technology (MRVL.US) rose 7.07% after announcing a partnership with Rebellions to provide AI systems for regional projects in Asia-Pacific and the Middle East [7] - Palo Alto Networks (PANW.US) fell 5.58% after agreeing to acquire CyberArk Software for approximately $25 billion [8]

Group 1 - The nuclear power sector experienced a rise on Wednesday, with Oklo Inc (OKLO.US) increasing by over 8% [2] - NANO Nuclear (NNE.US) saw an increase of over 5.8% [2] - NuScale Power (SMR.US) rose by over 3% [2]

Core Viewpoint - The nuclear power sector experienced a notable increase in stock prices, indicating positive market sentiment towards companies in this industry [1] Company Performance - Oklo Inc (OKLO.US) saw its stock price rise by over 8% [1] - NANO Nuclear (NNE.US) experienced a stock price increase of more than 5.8% [1] - NuScale Power (SMR.US) had a stock price increase of over 3% [1]

Core Insights - NuScale Power Corporation (SMR) is a leading firm in the nuclear energy sector, while Oklo Inc. (OKLO) is an emerging player with significant growth, having increased by 701.5% over the past year compared to SMR's 413.3% rise [1] Regulatory Readiness - NuScale Power has received approval from the U.S. Nuclear Regulatory Commission (NRC) for its reactor design, which is crucial for construction and deployment, a process that took over a decade and concluded in 2020 [4] - Oklo's business model heavily relies on U.S. government support, requiring favorable policies and NRC approval, which is currently in a slow and complex pre-application stage [5] Commercial Readiness - NuScale's reactor design is approved, targeting industries such as data centers, hydrogen production, and water desalination, with established customer interest and readiness for construction [7][8] - Oklo, while aiming for similar markets, is still in early development stages and has not yet built or delivered any power plants, with no revenues reported as of early 2025 [9] Valuation and Investor Sentiment - Despite its lack of earnings, Oklo is trading at a high price-to-book (P/B) ratio of 36.79, indicating investor optimism about its future potential, compared to NuScale's P/B of 26.30 [10] - Oklo's current valuation does not align with its fundamentals, leading to a recommendation against investment, while NuScale is suggested to be held due to lower execution risk and better near-term visibility [11][14]